date,title,source
Oct-19-18,"Clearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply Chain",GlobeNewswire
Oct-22-18,"CLEARSIDE, XIPERE and PEACHTREE to be Front and Center at AAO 2018",GlobeNewswire
Oct-25-18,"Clearside Biomedical Appoints Thomas A. Ciulla, M.D., MBA as Chief Medical Officer",GlobeNewswire
Oct-29-18,Presentation of Additional Analyses of Clearsides PEACHTREE Clinical Trial Data Further Supports Potential of XIPERE in Treating Uveitic Macular Edema,GlobeNewswire
Nov-05-18,"Clearside Biomedical to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018  Conference Call to Follow",GlobeNewswire
Nov-05-18,Clearside Biomedical Announces SAPPHIRE Phase 3 Study of Combination Therapy in Retinal Vein Occlusion Did Not Meet Its Primary Endpoint,GlobeNewswire
Nov-06-18,Todays Research Reports on Stocks to Watch: Teladoc Health and Clearside,ACCESSWIRE
Nov-07-18,Clearside Biomedical to Participate in Stifel 2018 Healthcare Conference,GlobeNewswire
Nov-08-18,Clearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Nov-09-18,Edited Transcript of CLSD earnings conference call or presentation 8-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-27-18,"Report: Exploring Fundamental Drivers Behind ForeScout Technologies, GNC, Dova Pharmaceuticals, CymaBay Therapeutics, Adesto Technologies, and Clearside Biomedical  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Dec-12-18,Edited Transcript of CLSD earnings conference call or presentation 8-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Dec-17-18,Edited Transcript of CLSD earnings conference call or presentation 8-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Dec-19-18,Clearside Biomedical Submits New Drug Application for XIPERE for the Treatment of Macular Edema Associated with Uveitis,GlobeNewswire
Dec-21-18,"Need To Know: Clearside Biomedical, Inc. (NASDAQ:CLSD) Insiders Have Been Buying Shares",Simply Wall St.
Jan-02-19,Clearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Feb-15-19,Healthcare Companies Positioned in Major Markets,ACCESSWIRE
Feb-19-19,Clearside Biomedicals Suprachoroidal Injection Platform Featured in Multiple Oral Presentations at 42nd Annual Meeting of The Macula Society,GlobeNewswire
Feb-20-19,Four Tech Stocks Bubbling with Excitement,ACCESSWIRE
Feb-20-19,"Recent Analysis Shows Cisco, Zendesk, Clearside Biomedical, Conn's, NIC, and Commercial Vehicle Group Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Feb-20-19,"Clearside Biomedical Receives Notification of FDA Acceptance of NDA Filing for XIPERE (triamcinolone acetonide ophthalmic suspension) for Suprachoroidal Injection with PDUFA Date Set for October 19, 2019",GlobeNewswire
